News

Apple's New Health AI Study

Apple has launched Apple Health AI Usage Study, a major research initiative that aims to understand how people use artificial intelligence (AI) …

Johnson & Johnson Acquisition of Ollin Biosciences

Johnson & Johnson (J&J) is reportedly considering to buy biotechnology company Ollin Biosciences in a deal worth up to $3.4 billion. The …

Meningitis Vaccine Warning in UK For 580,000 Young People Before The Deadline

The UK Health Security Agency (UKHSA) has issued a fresh meningitis vaccine warning in UK, urging more than 580,000 young people to …

Bristol Myers Squibb's New R&D Structure To Accelerate Drug Development Under New Leadership

Bristol Myers Squibb (BMS) is bringing its research and development operations together under one leader as the pharmaceutical company looks to accelerate …

Pfizer and Blackstone Obesity Drug Deal to Provide $1.5 Billion Funding for Drug Development

The Pharma giant Pfizer has secured up to $1.5 billion from Blackstone Life Sciences to accelerate the development of berobenatide, an experimental …

E. coli Outbreak in SLO County Claims One Life After Pumpkin Farm Exposure

One person has died following an E. coli outbreak in SLO County, California, linked to visits to Brookshire pumpkin farms. County health …

Simtra BioPharma's New Bloomington Plant With $250M+ Investment to Boost Drug Production

Simtra BioPharma Solutions has opened its new manufacturing facility in Bloomington, Indiana, following an investment of more than $250 million. Simtra BioPharma’s …

Google Gemini for Healthcare

Google Cloud has launched Gemini for Healthcare, a purpose-built artificial intelligence (AI) platform designed to connect fragmented healthcare systems and automate complex …

Novartis Zolgensma tumor cases

Novartis has disclosed nine reports of tumors in patients who previously received its spinal muscular atrophy (SMA) gene therapy, Zolgensma, raising fresh …

British Citizen With Ebola Returns to UK for Treatment

A British doctor who contracted Ebola while supporting the outbreak response in the Democratic Republic of Congo (DR Congo) has returned to …

AstraZeneca Rhythm Pharmaceuticals Acquisition to Expand Rare Disease Portfolio

AstraZeneca has reportedly made a non-binding offer worth approximately $10 billion to acquire Rhythm Pharmaceuticals, a US-based biotechnology company specialising in treatments …

Boehringer Sino Biopharma Cancer Drug Deal Hits $7.4B

Boehringer Ingelheim has signed a cancer drug licensing agreement with China’s Sino Biopharmaceutical (SBP Group) that could be worth up to $7.4 …